Legal Opinion

Fed. Trade Comm'n v. Quincy Bioscience Holding Co.

District Court, S.D. Illinois

Decided July 24, 2019No. 17 Civ. 124 (LLS)PublishedCited by 2 opinions

1Opinion of the Court

LOUIS L. STANTON, U.S.D.J.

Plaintiffs Federal Trade Commission ("FTC") and the People of the State of New York brought this action alleging violations of the Federal Trade Commission Act and New York law for deceptive advertising of a dietary supplement ("Prevagen") purporting to improve one's memory. Defendants move to dismiss the complaint for failure to state a claim upon which relief can be granted and for lack of personal jurisdiction over Mark Underwood and Michael Beaman. For the following reasons, the motion is granted in part and denied in part.

BACKGROUND

The following facts are as…

2Cases cited11 opinions

  1. Asahi Metal Industry Co. v. Superior Court of Cal., Solano Cty.Supreme Court of the United States · 1987
  2. IUE AFL-CIO Pension Fund v. HerrmannCourt of Appeals for the Second Circuit · 1993
  3. BNSF Ry. Co. v. TyrrellSupreme Court of the United States · 2017
  4. Daniel v. American Board of Emergency MedicineCourt of Appeals for the Second Circuit · 2005
  5. Federal Trade Commission v. Amy Travel Service, Inc., Resort Performance, Inc., Resort Telemarketing, Inc., Thomas P. McCann Ii, and James F. WeilandCourt of Appeals for the Seventh Circuit · 1989

6 more not listed; retrieve them via the Exa API.

3Cited by2 opinions

  1. Rittenhouse v. BlendJet, Inc.District Court, E.D. California · 2025
  2. United States of America and State of New York, ex rel. Patrick Donohue v. Richard Carranza, et.al.District Court, S.D. New York · 2022

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API